Cataplexy treated with escitalopram - Clinical experience

Neuroendocrinology Letters

Volumn 27, Issue 1-2, 2006, Pages 174-176

  Šonka, Karel ^a   Kemlink, David ^a   Pretl, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressants; Cataplexy; Escitalopram; Narcolepsy; Serotonin specific reuptake inhibitors

Indexed keywords

ESCITALOPRAM;

ADULT; AGED; ALERTNESS; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DRUG DOSE REGIMEN; DRUG EFFICACY; EJACULATION DISORDER; EXPERIENCE; FEMALE; HUMAN; MALE; MOOD; NARCOLEPSY; NIGHT SLEEP; PATIENT COMPLIANCE; SLEEP; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL;

EID: 33745648349     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. American Academy of Sleep Medicine: International classification of sleep disorders: Diagnostic and coding manual 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.
2. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003; 114:2000-2017.
3. Davidson JRI, Bose A, Wang Q. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. J Clin Psychiatry 2005; 66:1441-1446.
4. Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clornipramine hydrochloride. Acta Neurol Scand 1976; 54:171-187.
5. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14:540-545.
6. Langdon N, Bandak S, Shindler J, Parkes JD. Fluoxetine in the treatment of cataplexy. Sleep 1986; 9:371-372.
7. Llorca PM, Brousse G, Schwan R. Escitalopram for treatment of major depressive disorder in adults. Encephale 2005; 31:490-501.
8. Mignot, E. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy. Sleep Med Rev 2004; 8:333-338.
9. Sánchez C, Bergqvist PBF, Brennum LT, Gupta S, Hogg A, Larsen A, Wilborg O. Escitalopram the 5-(+)-enaciomer of citalopram, is a selective serotonin reuptake inhibitor with potent effect of animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology 2003; 167:353-362.
10. Schachter M, Parkes JD. Fluvoxamine and clornipramine in the treatment of cataplexy. J Neurol Neurosurg Psychiatry 1980; 43:171-174.
11. Smith M, Parkes JD, Dahlitz M. Venlafaxine in the treatment of the narcoleptic syndrome. J Sleep Res 1996;5(suppl.1):217.
12. U.S. Xyrem® Multicenter Study group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004; 5:119-123.